Mapol Inc. will be hosting our 7th Annual Private Payer Education and Training Seminars in MONTRÉAL ( and )TORONTO/BRAMPTON (. )This will be an opportunity for you to hear from key stakeholders about new developments being implemented and/or considered for private drug plans. Also, Mapol will be highlighting key trends and issues for 2016 and 2017. LEARN MORE
The modernization of benefits contract language, introduction of additional drug review processes and preferred provider networks were under the spotlight at the 2nd Annual Benefits Advisors’ Drug Plan Outlook. Mapol Inc., in partnership with Benefits and Pensions Monitor, brought together benefits advisors from across Canada with representatives of Canada’s brand pharmaceutical manufacturers on November 26, 2015 in Toronto at the Ritz Carlton Hotel. The purpose of this meeting was to review key developments and trends in the benefits industry as they pertain to drug plans, to understand how these changes have impacted benefits advisor / employer relations, and to find some ‘common ground’ to develop mutual solutions that will allow all stakeholders to work together more effectively.
Read article online
Mapol's 3rd Annual Benefits Advisors’ Drug Plan Outlook Meeting will be held on November 3, 2016 in Downtown Toronto. For information on sponsorship opportunities, please contact Corinne Razem at firstname.lastname@example.org
Mapol will be hosting a Private Payer PLAs Seminar on Wednesday June 8, 2016 from 8AM – 12PM noon at the Hilton Garden Inn, Toronto/Brampton. Registration Deadline: Friday June 3, 2016! This is a closed-door seminar for invited brand pharmaceutical manufacturers. Learn more
Green Shield Develops SEB Policy
Mapol Inc. will be hosting a breakfast session on Tuesday April 12 at 7:15 am where will will be discussing "Bringing Evidence to Private Payers"
Johnny Ma, President of Mapol will be moderating a panel discussion with the following Private Payers:
- Amy Lam, ClaimSecure
- Kevin Wong, TELUS Health
- Anne-Marie Smith, Medavie Blue Cross
Click here to learn more.